• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.

作者信息

Mirioglu Safak, Hocaoglu Rabia Hacer, Velioglu Arzu, Ozluk Yasemin, Dirim Ahmet Burak, Oruc Aysegul, Oto Ozgur Akin, Yazici Halil, Caliskan Yasar

机构信息

Division of Nephrology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.

Department of Immunology, Istanbul University Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.

出版信息

Clin Kidney J. 2024 Jun 20;17(7):sfae190. doi: 10.1093/ckj/sfae190. eCollection 2024 Jul.

DOI:10.1093/ckj/sfae190
PMID:39021814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11252667/
Abstract
摘要

相似文献

1
Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.尽管使用了依库珠单抗，但移植后C3肾小球病患者的预后仍然很差。
Clin Kidney J. 2024 Jun 20;17(7):sfae190. doi: 10.1093/ckj/sfae190. eCollection 2024 Jul.
2
Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.补体因子 D 抑制剂治疗 C3 肾小球病患者的临床应答模式。
Am J Kidney Dis. 2018 Jul;72(1):84-92. doi: 10.1053/j.ajkd.2017.11.019. Epub 2018 Feb 9.
3
Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study.依库珠单抗治疗 C3 肾小球病：单中心回顾性研究。
BMC Nephrol. 2023 Jan 11;24(1):8. doi: 10.1186/s12882-023-03058-9.
4
Treating C3 glomerulopathy with eculizumab.用依库珠单抗治疗C3肾小球病。
BMC Nephrol. 2018 Jan 12;19(1):7. doi: 10.1186/s12882-017-0802-4.
5
Successful Treatment of Posttransplant Recurrent Complement C3 Glomerulopathy with Eculizumab.依库珠单抗成功治疗移植后复发性补体C3肾小球病
Iran J Kidney Dis. 2018 Oct;12(5):315-318.
6
[Translated article] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.[翻译文章] 依库珠单抗在成人和儿科非典型溶血尿毒综合征及 C3 肾小球病患者中的药代动力学。
Farm Hosp. 2024 Jan-Feb;48(1):T16-T22. doi: 10.1016/j.farma.2023.09.009. Epub 2023 Dec 5.
7
Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.依库珠单抗在成人和儿科非典型溶血性尿毒症综合征及 C3 肾小球病患者中的药代动力学。
8
Eculizumab for treatment of rapidly progressive C3 glomerulopathy.依库珠单抗治疗快速进展性 C3 肾小球病。
Am J Kidney Dis. 2015 Mar;65(3):484-9. doi: 10.1053/j.ajkd.2014.09.025. Epub 2014 Dec 17.
9
Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft.依库珠单抗作为补救疗法治疗肾移植中复发性单克隆丙种球蛋白血症相关 C3 肾小球病。
BMC Nephrol. 2018 May 3;19(1):106. doi: 10.1186/s12882-018-0904-7.
10
Treatment of C3 Glomerulopathy in Adult Kidney Transplant Recipients: A Systematic Review.成人肾移植受者C3肾小球病的治疗：一项系统评价
Med Sci (Basel). 2020 Oct 21;8(4):44. doi: 10.3390/medsci8040044.

引用本文的文献

1
Kidney transplant in patients with C3 glomerulopathy.C3肾小球病患者的肾移植
Clin Kidney J. 2025 Apr 30;18(5):sfaf134. doi: 10.1093/ckj/sfaf134. eCollection 2025 May.
2
Complement-Mediated Kidney Disease and Living Donor Transplantation: Tailoring Approaches to Improve Outcomes.补体介导的肾脏疾病与活体供肾移植：定制改善预后的方法。
Curr Transplant Rep. 2025;12(1). doi: 10.1007/s40472-025-00466-8. Epub 2025 Apr 16.
3
Kidney Transplantation in Children and Adolescents With C3 Glomerulopathy or Immune Complex Membranoproliferative Glomerulonephritis: An International Survey of Current Practice.儿童及青少年C3肾小球病或免疫复合物膜增生性肾小球肾炎的肾移植：当前实践的国际调查
Pediatr Transplant. 2025 Mar;29(2):e70048. doi: 10.1111/petr.70048.

本文引用的文献

1
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.依他卡帕对C3肾小球病患者的疗效和安全性
Kidney Int Rep. 2023 Sep 22;8(12):2754-2764. doi: 10.1016/j.ekir.2023.09.017. eCollection 2023 Dec.
2
Poor allograft outcome in Indian patients with post-transplant C3 glomerulopathy.印度移植后C3肾小球病患者同种异体移植预后不佳。
Clin Kidney J. 2019 Nov 4;14(1):291-300. doi: 10.1093/ckj/sfz135. eCollection 2021 Jan.
3
Treatment of C3 Glomerulopathy in Adult Kidney Transplant Recipients: A Systematic Review.成人肾移植受者C3肾小球病的治疗：一项系统评价
Med Sci (Basel). 2020 Oct 21;8(4):44. doi: 10.3390/medsci8040044.
4
Kidney Transplantation in C3 Glomerulopathy: A Case Series.C3 肾小球病的肾移植：病例系列。
Am J Kidney Dis. 2019 Mar;73(3):316-323. doi: 10.1053/j.ajkd.2018.09.002. Epub 2018 Nov 7.
5
Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.补体因子 D 抑制剂治疗 C3 肾小球病患者的临床应答模式。
Am J Kidney Dis. 2018 Jul;72(1):84-92. doi: 10.1053/j.ajkd.2017.11.019. Epub 2018 Feb 9.
6
C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.在一项美国大型 C3 肾小球病患者队列中，C3 肾小球肾炎和致密物沉积病具有相似的疾病进程。
Kidney Int. 2018 Apr;93(4):977-985. doi: 10.1016/j.kint.2017.10.022. Epub 2018 Jan 6.
7
Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.肾移植后C3肾小球肾炎（C3GN）的临床发现、病理及转归
J Am Soc Nephrol. 2014 May;25(5):1110-7. doi: 10.1681/ASN.2013070715. Epub 2013 Dec 19.